[Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
Adrenal scintigraphy with 131I-6 beta-iodomethyl-19-noncholesterol requires well-prepared patients. Its interpretation requires trained observers with good knowledge of adrenal physiology and adrenal diseases. This multidisciplinary cooperative work was conducted by endocrinologists, nuclear medicine physicians and surgeons, in order to help physicians to optimize indications and practical implementation of this scintigraphy, which has constraints and pitfalls but is very informative.
Bardet
S
S
Service de Médecine Nucléaire, Centre François Baclesse, Caen.
Nocaudie-Calzada
M
M
Kraimps
J L
JL
Tabarin
A
A
Wémeau
J L
JL
D015071:19-Iodocholesterol / Q000031:analogs & derivatives*; D000311:Adrenal Glands / Q000000981:diagnostic imaging*; D006801:Humans; D007457:Iodine Radioisotopes; D011877:Radionuclide Imaging
D007457:Iodine Radioisotopes; D015071:19-Iodocholesterol; C035501:6-iodomethylcholesterol
Exploration scintigraphique des corticosurrénales au 131I-6 beta-iodométhyl-19-norcholestérol: guide de bonne pratique.